Induction of immunological tolerance by oral anti-CD3

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Da Cunha, Andre Pires ^a   Weiner, Howard L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MONOCLONAL ANTIBODY CD3; OKT 3; PLACEBO; CD3 ANTIGEN; MONOCLONAL ANTIBODY;

ABSENCE OF SIDE EFFECTS; ACUTE GRAFT REJECTION; ALLERGIC ENCEPHALOMYELITIS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; DIABETES MELLITUS; DISEASE COURSE; DRUG BINDING; DRUG EFFICACY; DRUG MECHANISM; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; LUPUS VULGARIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIATIC ARTHRITIS; REGULATORY T LYMPHOCYTE; REMISSION; REVIEW; T CELL DEPLETION; IMMUNOLOGY; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; AUTOIMMUNE DISEASES; HUMANS; IMMUNE TOLERANCE;

EID: 84855163123     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/425021     Document Type: Review

References (41)

1. Weiner H. L., da Cunha A. P., Quintana F., Wu H., Oral tolerance Immunological Reviews 2011 241 1 241 259
2. Vaz N. M., Maia L. C. S., Hanson D. G., Lynch J. M., Inhibition of homocytotropic antibody responses in adult inbred mice by previous feeding of the specific antigen Journal of Allergy and Clinical Immunology 1977 60 2 110 115 (Pubitemid 8167881)
3. Faria A. M. C., Weiner H. L., Oral tolerance: therapeutic implications for autoimmune diseases Clinical and Developmental Immunology 2006 13 2-4 143 157 (Pubitemid 44950033)
4. Strobel S., Mowat A. M., Oral tolerance and allergic responses to food proteins Current Opinion in Allergy and Clinical Immunology 2006 6 3 207 213 (Pubitemid 44510205)
5. Chen Y., Inobe J. I., Kuchroo V. K., Baron J. L., Janeway C. A., Weiner H. L., Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells Proceedings of the National Academy of Sciences of the United States of America 1996 93 1 388 391 (Pubitemid 26038164)
6. Chen Y., Inobe J. I., Marks R., Gonnella P., Kuchroo V. K., Weiner H. L., Peripheral deletion of antigen-reactive T cells in oral tolerance Nature 1995 376 6536 177 180
7. Sun C. M., Hall J. A., Blank R. B., Bouladoux N., Oukka M., Mora J. R., Belkaid Y., Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid Journal of Experimental Medicine 2007 204 8 1775 1785 (Pubitemid 47236316)
8. Zhang X., Izikson L., Liu L., Weiner H. L., Activation of CD25 + CD4 + regulatory T cells by oral antigen administration Journal of Immunology 2001 167 8 4245 4253 (Pubitemid 32954298)
9. Thorstenson K. M., Khoruts A., Generation of anergic and potentially immunoregulatory CD25 + CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen Journal of Immunology 2001 167 1 188 195 (Pubitemid 32567777)
10. Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T., Miyara M., Fehervari Z., Nomura T., Sakaguchi S., CTLA-4 control over Foxp3+ regulatory T cell function Science 2008 322 5899 271 275
11. Bluestone J. A., Mechanisms of tolerance Immunological Reviews 2011 241 1 5 19
12. Belghith M., Bluestone J. A., Barriot S., Mégret J., Bach J. F., Chatenoud L., TGF- -dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes Nature Medicine 2003 9 9 1202 1208 (Pubitemid 37173706)
13. Chatenoud L., Thervet E., Primo J., Bach J. F., Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice Proceedings of the National Academy of Sciences of the United States of America 1994 91 1 123 127 (Pubitemid 24018655)
14. Herold K. C., Bluestone J. A., Montag A. G., Parihar A., Wiegner A., Gress R. E., Hirsch R., Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody Diabetes 1992 41 3 385 391
15. Kohm A. P., Williams J. S., Bickford A. L., McMahon J. S., Chatenoud L., Bach J. F., Bluestone J. A., Miller S. D., Treatment with nonmitogenic anti-CD3 monoclonal antibody induces CD4+ T cell unresponsiveness and functional reversal of established experimental autoimmune encephalomyelitis Journal of Immunology 2005 174 8 4525 4534
16. Tran G. T., Carter N., He X. Y., Spicer T. S., Plain K. M., Nicolls M., Hall B. M., Hodgkinson S. J., Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferntial effect on Th1 cells that is augmented by IL-4 International Immunology 2001 13 9 1109 1120 (Pubitemid 32899153)
17. Herold K. C., Gitelman S. E., Masharani U., Hagopian W., Bisikirska B., Donaldson D., Rother K., Diamond B., Harlan D. M., Bluestone J. A., A single course of anti-CD3 monoclonal antibody hOKT3 1(ala-ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes Diabetes 2005 54 6 1763 1769 (Pubitemid 40770766)
18. Herold K. C., Hagopian W., Auger J. A., Poumian-Ruiz E., Taylor L., Donaldson D., Gitelman S. E., Harlan D. M., Xu D., Zivin R. A., Bluestone J. A., Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus New England Journal of Medicine 2002 346 22 1692 1698 (Pubitemid 34547482)
19. Herold K. C., Taylor L., Treatment of type 1 diabetes with anti-CD3 monoclonal antibody: induction of immune regulation? Immunologic Research 2003 28 2 141 150 (Pubitemid 37465163)
20. Utset T. O., Auger J. A., Peace D., Zivin R. A., Xu D., Jolliffe L., Alegre M. L., Bluestone J. A., Clark M. R., Modified anti-CD3 therapy in psoriatic arthritis: a Phase I/II clinical trial Journal of Rheumatology 2002 29 9 1907 1913 (Pubitemid 34988699)
21. Chatenoud L., CD3-specific antibody-induced active tolerance: from bench to bedside Nature Reviews Immunology 2003 3 2 123 132 (Pubitemid 37328690)
22. Chatenoud L., CD3-specific antibodies as promising tools to aim at immune tolerance in the clinic International Reviews of Immunology 2006 25 3-4 215 233 (Pubitemid 44034581)
23. Alegre M. L., Peterson L. J., Xu D., Sattar H. A., Jeyarajah D. R., Kowalkowski K., Thistlethwaite J. R., Zivin R. A., Jolliffe L., Bluestone J. A., A non-activating 'humanized' anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo Transplantation 1994 57 11 1537 1543
24. Bolt S., Routledge E., Lloyd I., Chatenoud L., Pope H., Gorman S. D., Clark M., Waldmann H., The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties European Journal of Immunology 1993 23 2 403 411 (Pubitemid 23075070)
25. Chatenoud L., Bluestone J. A., CD3-specific antibodies: a portal to the treatment of autoimmunity Nature Reviews Immunology 2007 7 8 622 632 (Pubitemid 47123550)
26. Slavin A. J., Maron R., Weiner H. L., Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes International Immunology 2001 13 6 825 833 (Pubitemid 32514708)
27. Miyamoto K., Kingsley C. I., Zhang X., Jabs C., Izikson L., Sobel R. A., Weiner H. L., Kuchroo V. K., Sharpe A. H., The ICOS molecule plays a crucial role in the development of mucosal tolerance Journal of Immunology 2005 175 11 7341 7347 (Pubitemid 41713430)
28. Peron J. P. S., Yang K., Chen M. L., Brandao W. N., Basso A. S., Commodaro A. G., Weiner H. L., Rizzo L. V., Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice Journal of Neuroimmunology 2010 227 1-2 10 17
29. Ochi H., Abraham M., Ishikawa H., Frenkel D., Yang K., Basso A. S., Wu H., Chen M. L., Gandhi R., Miller A., Maron R., Weiner H. L., Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4 + CD25 - LAP + T cells Nature Medicine 2006 12 6 627 635 (Pubitemid 43865230)
30. Ishikawa H., Ochi H., Chen M. L., Frenkel D., Maron R., Weiner H. L., Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody Diabetes 2007 56 8 2103 2109 (Pubitemid 47195835)
31. Ilan Y., Zigmond E., Lalazar G., Dembinsky A., Ben Ya'Acov A., Hemed N., Kasis I., Axelrod E., Zolotarov L., Klein A., El Haj M., Gandhi R., Baecher-Allan C., Wu H., Murugaiyan G., Kivisakk P., Farez M. F., Quintana F. J., Khoury S. J., Weiner H. L., Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells Journal of Clinical Immunology 2010 30 1 167 177
32. Ilan Y., Maron R., Tukpah A. M., Maioli T. U., Murugaiyan G., Yang K., Wu H. Y., Weiner H. L., Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice Proceedings of the National Academy of Sciences of the United States of America 2010 107 21 9765 9770
33. Wu H. Y., Center E. M., Tsokos G. C., Weiner H. L., Suppression of murine SLE by oral anti-CD3: inducible CD4 + CD25 - LAP + regulatory T cells control the expansion of IL-17+ follicular helper T cells Lupus 2009 18 7 586 596
34. Wu H. Y., Maron R., Tukpah A. M., Weiner H. L., Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant Journal of Immunology 2010 185 6 3401 3407
35. Sasaki N., Yamashita T., Takeda M., Shinohara M., Nakajima K., Tawa H., Usui T., Hirata K. I., Oral anti-CD3 antibody treatment induces regulatory t cells and inhibits the development of atherosclerosis in mice Circulation 2009 120 20 1996 2005
36. Oida T., Weiner H. L., Overexpression of TGF- 1 gene induces cell surface localized glucose-regulated protein 78-associated latency-associated peptide/TGF- Journal of Immunology 2010 185 6 3529 3535
37. Wu H. Y., Quintana F. J., Weiner H. L., Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4 + CD25 - LAP + regulatory T Cell and is associated with down-regulation of IL-17 + CD4 + ICOS + CXCR5 + follicular helper T cells Journal of Immunology 2008 181 9 6038 6050
38. Weiner H. L., The mucosal milieu creates tolerogenic dendritic cells and TR l and TH3 regulatory cells Nature Immunology 2001 2 8 671 672 (Pubitemid 32747154)
39. Miller A., Lider O., Weiner H. L., Antigen-driven bystander suppression after oral administration of antigens Journal of Experimental Medicine 1991 174 4 791 798
40. NasVax, NasVax Announces the Success of a Phase 2a Clinical Trial of a New Oral Immunotherapy for Fatty Liver Disease. 2011, http://www.businesswire. com/news/home/20110321005934/en/NasVax-Announces-Success-Phase-2a-Clinical-Trial
41. Kuhn C., You S., Valette F., Hale G., Van Endert P., Bach J. -F., Waldmann H., Chatenoud L., Human CD3 transgenic mice: preclinical testing of antibodies promoting immune tolerance Science Translational Medicine 2011 3 68, article 68ra10